5-phenyl-1h-3-benzazepine derivatives
CA 1091665 A · Owner: Sandoz Ltd. · Inventors: Bream, John B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of the disclosure, Compounds of formula I I, wherein either R1 is hydrogen, halogen trifluoromethyl, or lower alkyl or alkoxy and, R2 is hydrogen or lower alkoxy , or R1 and R2 together are methylenedioxy, R3 is hydrogen halogen, trifluoromethyl, lower alkyl or alkoxy or alkylsulphonyl R4 is hydrogen, halogen, lower alkyl or alkoxy, and, either (i) R5 is hydrogen lower alkyl or hydroxy-, alkyl, lower alkyl mono-substituted by cycloalkyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms lower, alkenyl or alkynyl, wherein the multiple bond is in other than the .alpha..beta.-position or phenylalkyl of 7 to 10 carbon atoms and, R6 is hydrogen, lower alkyl or hydroxyalkyl, or, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted December 16, 1980. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 16, 1997.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.